⌘K

Home/Filings/4/0001213900-18-003155

4//SEC Filing

Berger Mark Stanley 4

Accession 0001213900-18-003155

CIK 0001388320other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 5:04 PM ET

Size

9.1 KB

Accession

0001213900-18-003155

Insider Transaction Report

Form 4

Period: 2018-03-06

Actinium Pharmaceuticals, Inc.ATNM

Berger Mark Stanley

Chief Medical Officer

Transactions

Other
Common Stock
2018-03-06$0.50/sh+14,000$7,000→ 19,000 total
Other
Series B Warrants
2018-03-06$0.50/sh+10,500$5,250→ 10,500 total
Exercise: $0.70From: 2018-03-06Exp: 2020-09-06→ Common Stock (10,500 underlying)
Other
Series A Warrants
2018-03-06$0.50/sh+3,500$1,750→ 3,500 total
Exercise: $0.60From: 2018-03-06Exp: 2019-03-06→ Common Stock (3,500 underlying)

Documents

1 file

4
f4030618berger_actinium.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeother

Related Parties

1

filerCIK 0001700283

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 5:04 PM ET
Size: 9.1 KB

View on SEC.gov